Lv1
100 积分 2024-03-11 加入
Factor V is an anticoagulant of the extrinsic pathway of coagulation and modifier of thrombin generation in hemophilia A
1个月前
已关闭
A novel bispecific antibody drug conjugate targeting HER2 and HER3 with potent therapeutic efficacy against breast cancer
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
1个月前
已完结
Exploring the next generation of antibody–drug conjugates
1个月前
已完结
Biosynthetic human growth hormone: subchronic toxicity studies in rats and monkeys
1个月前
已完结
Monitoring of Coagulation Potential of Efanesoctocog Alfa in Haemophilia A: Insights From Conventional and Global Hemostasis Assays
2个月前
已完结
Nonclinical pharmacokinetic and pharmacodynamic characterisation of somapacitan: A reversible non-covalent albumin-binding growth hormone
2个月前
已完结
Pharmacokinetic/pharmacodynamic (PK/PD) differentiation of native and PEGylated recombinant human growth hormone (rhGH and PEG-rhGH) in the rat model of osteoarthritis
2个月前
已完结
Reformulated BeneFix®: efficacy and safety in previously treated patients with moderately severe to severe haemophilia B
3个月前
已完结
Challenges for new haemophilia products from a manufacturer’s perspective
3个月前
已完结
皖公网安备34019202002308
